These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 6325716

  • 1. Effect of palmitoyl carnitine on Na+, K+-ATPase and adenylate cyclase activity of canine myocardial sarcolemma.
    Abe M, Yamazaki N, Suzuki Y, Kobayashi A, Ohta H.
    J Mol Cell Cardiol; 1984 Mar; 16(3):239-45. PubMed ID: 6325716
    [Abstract] [Full Text] [Related]

  • 2. Effects of palmitoyl carnitine and LPC on cardiac sarcolemmal Na+-K+-ATPase.
    Pitts BJ, Okhuysen CH.
    Am J Physiol; 1984 Nov; 247(5 Pt 2):H840-6. PubMed ID: 6093598
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of sarcolemmal Na+-K+-ATPase by palmitoyl carnitine: potentiation by propranolol.
    Kramer JH, Weglicki WB.
    Am J Physiol; 1985 Jan; 248(1 Pt 2):H75-81. PubMed ID: 2982278
    [Abstract] [Full Text] [Related]

  • 4. Effects of fatty acid intermediates on Na+-K+-ATPase activity of cardiac sarcolemma.
    Owens K, Kennett FF, Weglicki WB.
    Am J Physiol; 1982 Mar; 242(3):H456-61. PubMed ID: 6278956
    [Abstract] [Full Text] [Related]

  • 5. The effect of lipid intermediates on Ca2+ and Na+ permeability and (Na+ + K+)-ATPase of cardiac sarcolemma. A possible role in myocardial ischemia.
    Lamers JM, Stinis HT, Montfoort A, Hülsmann WC.
    Biochim Biophys Acta; 1984 Jul 11; 774(1):127-37. PubMed ID: 6329291
    [Abstract] [Full Text] [Related]

  • 6. Role of membrane integrity and cation interaction for heart sarcolemmal adenylate cyclase and Na+-K+ ATPase.
    Chauhan MS, Anand-Srivastava MB, Panagia V, Dhalla NS.
    Adv Myocardiol; 1982 Jul 11; 3():317-27. PubMed ID: 6302775
    [Abstract] [Full Text] [Related]

  • 7. Evidence against a regulation of Na+/K(+)-ATPase by Gi proteins. Failure to detect an influence of G proteins on Na+/Ca(2+)-exchange in cardiac sarcolemmal membranes.
    Mura RA, Zeifang F, Piacentini L, Kübler W, Rauch B, Niroomand F.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr 11; 353(5):505-12. PubMed ID: 8740143
    [Abstract] [Full Text] [Related]

  • 8. Two site binding of bepridil and modulation of adenylate cyclase in cardiac sarcolemmal membranes.
    Cramb G, Dow JW.
    Biochim Biophys Acta; 1983 Dec 07; 736(1):99-108. PubMed ID: 6317030
    [Abstract] [Full Text] [Related]

  • 9. Control of cardiac sarcolemmal adenylate cyclase and sodium, potassium-activated adenosinetriphosphatase activities.
    Tada M, Kirchberger MA, Iorio JM, Katz AM.
    Circ Res; 1975 Jan 07; 36(1):8-17. PubMed ID: 123180
    [Abstract] [Full Text] [Related]

  • 10. Comparison of heart sarcolemmal enzyme activities in normal and cardiomyopathic (UM-X7.1) hamsters.
    Dhalla NS, Singh JN, Bajusz E, Jasmin G.
    Clin Sci Mol Med; 1976 Sep 07; 51(3):233-42. PubMed ID: 134861
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interaction of palmitoyl carnitine with calcium antagonists in myocytes.
    Patmore L, Duncan GP, Spedding M.
    Br J Pharmacol; 1989 Jun 07; 97(2):443-50. PubMed ID: 2474346
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of vanadium in the +5, +4 and +3 oxidation states on cardiac force of contraction, adenylate cyclase and (Na+ + K+)-ATPase activity.
    Schmitz W, Scholz H, Erdmann E, Krawietz W, Werdan K.
    Biochem Pharmacol; 1982 Dec 01; 31(23):3853-60. PubMed ID: 6297502
    [Abstract] [Full Text] [Related]

  • 16. Cardiac sarcolemmal Na+-K+-ATPase: combined effects of propranolol and arachidonyl CoA.
    Kramer JH, Owens K, Weglicki WB.
    Am J Physiol; 1983 May 01; 244(5):H738-42. PubMed ID: 6303134
    [Abstract] [Full Text] [Related]

  • 17. Effects of some L-carnitine derivatives on heart membrane ATPases.
    Dhalla NS, Kolár F, Shah KR, Ferrari R.
    Cardiovasc Drugs Ther; 1991 Feb 01; 5 Suppl 1():25-30. PubMed ID: 1851632
    [Abstract] [Full Text] [Related]

  • 18. [M-cholinoreceptor-mediated inhibition of Na, K-ATPase activity in the myocardial sarcolemma and intestinal smooth muscles by acetylcholine].
    Danilenko MP, Esyrev OV, Omarova RD, Smagulova ZSh, Turmukhambetova VK.
    Biull Eksp Biol Med; 1984 Sep 01; 98(9):259-61. PubMed ID: 6091807
    [Abstract] [Full Text] [Related]

  • 19. [M-cholinergic regulation of Na+,K+-ATPase activity of vesicular preparations of sarcolemma from the myocardium and intestinal smooth muscles].
    Danilenko MP, Smagulova ZSh, Turmukhambetova VK, Omarova RD, Esyrev OV.
    Ukr Biokhim Zh (1978); 1988 Sep 01; 60(1):55-60. PubMed ID: 2834846
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.